NCT07134023 Educational Program for the Multidisciplinary Support of Patients With Endometriosis
| NCT ID | NCT07134023 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier Emile Roux |
| Condition | Endometriosis |
| Study Type | INTERVENTIONAL |
| Enrollment | 260 participants |
| Start Date | 2025-12-17 |
| Primary Completion | 2029-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 260 participants in total. It began in 2025-12-17 with a primary completion date of 2029-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Background: Endometriosis is a chronic gynecological condition characterized by the ectopic presence of endometrial tissue outside the uterine cavity. It affects approximately 2 to 10% of women of reproductive age and up to 50% of women with chronic pelvic pain. In France, between 1.5 and 2.5 million women are estimated to be affected. Endometriosis significantly impairs quality of life, with consequences on cognitive, behavioral, sexual, and emotional well-being, and has substantial socio-economic impact. Rationale: Current medical and surgical treatments primarily aim to reduce pain and preserve fertility but show limited effectiveness and are often discontinued due to adverse effects. Many women resort to self-management strategies, which may pose risks if not properly supervised. A multidisciplinary and integrative approach is essential to address the complex and multifactorial symptoms of endometriosis. Therapeutic patient education (TPE) is a recommended strategy that can empower patients in the management of chronic conditions, yet remains underdeveloped in endometriosis care pathways. Objective: This study aims to evaluate the effectiveness of a multidisciplinary educational program combined with nurse-led telephone follow-up on the quality of life of patients with endometriosis. Methods: The intervention will consist of a series of workshops led by various healthcare professionals (medical and paramedical), alongside regular nurse-led telephone follow-up. This approach intends to provide continuous support, assess patients' evolving needs, and facilitate access to supportive care services, particularly within regional endometriosis networks (ENDAURA and ENDOSUD). Expected Outcomes: The study will assess whether this intervention improves quality of life among women with endometriosis. It also aims to provide evidence for the scalability and transferability of such a program at a national level, in alignment with current public health priorities.
Eligibility Criteria
Inclusion Criteria: * Signed informed consent, * Age ≥ 18 years, * Patient diagnosed with endometriosis confirmed by pelvic ultrasound and/or MRI, * Patient experiencing chronic pelvic-perineal pain (± dysmenorrhea, dyspareunia, etc.) for at least 3 months, * Ability to read and understand French, * Affiliation with a social security system or equivalent. Exclusion Criteria: * Patient having already participated in an educational program or received multidisciplinary follow-up (involving at least 3 different healthcare professionals simultaneously within the same facility) in the past 12 months, * Patient in an emergency situation, or under legal protection measures (guardianship, curatorship, or judicial protection) and unable to give consent, * For patients at the experimental center only: inability to comply with study follow-up due to geographical, social, or psychological reasons.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07134023 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Endometriosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07134023 currently recruiting?
Yes, NCT07134023 is actively recruiting participants. Contact the research team at petale@ch-lepuy.fr for enrollment information.
Where is the NCT07134023 trial being conducted?
This trial is being conducted at Aix-en-Provence, France, Le Puy-en-Velay, France.
Who is sponsoring the NCT07134023 clinical trial?
NCT07134023 is sponsored by Centre Hospitalier Emile Roux. The trial plans to enroll 260 participants.